Bio & context
Outspoken activist investor known for taking large stakes in companies and pushing for major changes to unlock value.
Bill Ackman founded Pershing Square Capital in 2004 after his previous fund Gotham Partners closed. He's famous for activist campaigns—taking 5-20% stakes in undervalued companies, then aggressively pushing management to make changes (spinoffs, buybacks, CEO replacement, asset sales). Major wins include Canadian Pacific Railway (quadrupled), General Growth Properties (10x return from bankruptcy), and his legendary COVID hedge in February 2020 that turned $27M into $2.6B in 30 days. However, Ackman has also had spectacular failures: his $1B short of Herbalife lost money for years, and his Valeant Pharmaceuticals investment cratered 90%. Known for his public battles, CNBC appearances, and 300-page investor presentations. His approach combines fundamental analysis with corporate activism and public advocacy.
Philosophy in their own words
Buy great businesses at good prices, then push management to unlock value. Public pressure can accelerate change.
Approach & method
Concentrated portfolio of 8-12 stocks. Deep fundamental analysis to identify mispriced businesses with hidden value. Build activist positions (5-20% ownership) to influence management. Push for operational improvements, capital allocation changes, board seats, or strategic alternatives. Very long holding periods (3-7 years) for winning positions.
Key strategies
- 1. Activist Campaigns: Buy 5-20% stakes, push for board seats, CEO changes, strategic alternatives
- 2. Concentrated Bets: 8-12 position portfolio, each position 10-15% of fund
- 3. Public Advocacy: Use media, investor presentations, and letters to pressure management
- 4. Special Situations: Target companies in distress, turnarounds, or with hidden value
- COVID hedge: $27M → $2.6B in 30 days (March 2020)
- Canadian Pacific Railway: 300%+ return, led CEO replacement
- General Growth Properties: Bought in bankruptcy, 10x return
- Pershing Square AUM: $10.5B (2024)
- Chipotle turnaround: Engineered CEO change, stock tripled
- Netflix investment: Bought at $58, sold at $300+
- Public campaigns against JCPenney, Herbalife, Valeant
- Wrote 300-page presentation on Allergan takeover
Key metrics
- 16.5% annual returns since 2004 inception
- COVID hedge: 9,600% return in 1 month
- Canadian Pacific: 300%+ over 4 years
- Worst year: -20.5% in 2015 (Valeant disaster)
Herbalife short (2012-2018) cost hundreds of millions. Valeant Pharmaceuticals investment lost 90%. High-profile public battles polarizing.